- Home
- MDCX
MDCX
Medicus Pharma Ltd.
as of 10-05-2026 3:43pm EST
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | W. CONSHOHOCKEN |
| Market Cap: | 10.9M | IPO Year: | 2025 |
| Target Price: | $4.50 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.43 | EPS Growth: | -136.21 |
| 52 Week Low/High: | $0.14 - $2.78 | Next Earning Date: | 11-13-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -0.37 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Compare MDCX vs Leading Stocks
See how MDCX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MDCX Medicus Pharma Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.